27-May-2019: The global DNA & gene chip
market size is expected to reach USD 10.7 billion by 2025, according to a new
report by Grand View Research, Inc., at an 11.4% CAGR during the forecast
period. DNA and gene chips have gained much success in providing high throughput
capabilities for comprehensive genome studies to enhance disease knowledge and
target them. This technology has emerged as a valuable and promising solution
across various aspects of disease management. These factors have been driving
the market.
About Grand View Research
Conventional means of gene
analysis allow investigation of relatively small amounts of genes at a time,
which further emphasizes on the uptake of DNA microarray technology. DNA
microarray technology allows concurrent analysis of very large numbers of
nucleic acid fragments in a single experiment.
Continuous development of new
tools to support and enhance reliability of DNA microarray technology is likely
to drive this market at a significant pace in the foreseeable future.
Furthermore, healthcare entities are engaged in exploiting novel solutions for
enhancing and combining data generated from gene chip with data generated from
high throughput technologies. Mutually beneficial partnerships between
microarray developers and pharmaceutical/biopharmaceutical companies for
acceleration of genomic and biomedical research activities is anticipated to
spur market growth in the coming years.
In
depth research report on DNA and Gene Chip Market
Further
key findings from the report suggest:
· Based
on product, consumables dominated the market with the largest share. This is
due to presence of large number of entities engaged in providing reagents and
kits associated with the use of DNA chips
· The
cancer treatment and diagnosis segment accounts for a significant share in the
market owing to rising inclination toward development of companion diagnostics
and growing usage of DNA microarrays in cancer diagnosis and treatment
· Implementation
of gene chip for drug discovery is also expected to increase in the coming
years owing to growing demand for personalized medicine
· By end
use, academic/government research institutes accounted for the largest share in
2017. Ongoing research projects on gene expression analysis in these institutes
have attributed for the estimated share
· In
terms of region, North America dominated the market with by revenue. High
penetration of major revenue generating companies in U.S. has contributed to
its leading share
· Asia
Pacific is projected to witness the fastest year-on-year growth owing to rising
healthcare spending in developing economies and increase in R&D investment
· Some of
the prominent market participants are Agilent Technologies; Thermo Fisher
Scientific, Incorporated (Affymetrix, Inc.); Illumina, Inc.; Macrogen Inc.; and
Arrayit Corporation. These players are engaged in mutual partnerships with
research communities and other diagnostic firms for use of gene chips for
targeting disease prognosis.
Grand View Research has
segmented the global DNA & gene chip market on the basis of application,
product, end use, and region:
DNA
& Gene Chip Application Outlook (Revenue, USD Million, 2014 - 2025)
· Cancer
diagnosis and treatment
· Gene
expression
· Genotyping
· Genomics
· Drug
discovery
· Agricultural
biotechnology
· Others
DNA
& Gene Chip Product Outlook (Revenue, USD Million, 2014 - 2025)
· Consumables
· Instrumentation
DNA
& Gene Chip End-use Outlook (Revenue, USD Million, 2014 - 2025)
· Academic
& Government Research Institutes
· Hospitals
& Diagnostics Centers
· Biotechnology
& Pharmaceutical Companies
· Others
Browse
more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
No comments:
Post a Comment